NSIM
XERS icon

North Star Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

North Star Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.92K Buy
+1,000
New +$6.39K ﹤0.01% 1129
2021
Q1 		– Sell
-2,000
Closed -$10K – 1086
2020
Q4 		$10K Buy
+2,000
New +$10K ﹤0.01% 780

Other funds holding XERS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

North Star Investment Management's XERS Position: Q2 2026 in Review

North Star Investment Management opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 1,000 shares worth $7.92K. The stake represents ﹤0.01% of the portfolio and ranks #1129 among its holdings. This is a return to the name: North Star Investment Management previously reported a position in XERS as recently as Q4 2020.

North Star Investment Management first reported a position in XERS in Q4 2020 and has held it in 2 quarters since. The position peaked at $10K in Q4 2020. 34 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • North Star Investment Management held 1,000 shares of Xeris Biopharma Holdings worth $7.92K as of Q2 2026.
  • Xeris Biopharma Holdings was a new North Star Investment Management position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1129 holding.
  • North Star Investment Management first reported a position in Xeris Biopharma Holdings in Q4 2020 and has held it in 2 quarters since.
  • North Star Investment Management's Xeris Biopharma Holdings position peaked at $10K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.